Search Results | Cancer Research | American Association for Cancer Research

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Abstract 1449: ApoStream™, a new dielectrophoretic device for antibody-independent isolation and recovery of circulating tumor cells from blood of patients with metastatic pancreatic adenocarcinoma.

Gauri Varadhachary, James Abbruzzese, Rachna Shroff, Vladislava Melnikova, Vishal Gupta, Chris Neal, Miguel Garza, David K. Hasegawa, Kenna L. Anderes, Darren Davis, Robert A. Wolff

Cancer Res (2013) 73 (8_Supplement): 1449.

DOI: https://doi.org/10.1158/1538-7445.AM2013-1449

Published: 15 April 2013

View article

Journal Articles

Abstract #2718: Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation

Dmitri Talantov, Gauri Varadhachary, Martin Raber, Timothy Jatkoe, Christina Meng, Kenneth Hess, Renato Lenzi, David Spigel, Anthony Greco, James Abbruzzese, Yixin Wang, John Hainsworth

Cancer Res (2009) 69 (9_Supplement): 2718.

Published: 01 May 2009

View article

Journal Articles

Abstract #2139: The association between diabetes mellitus and hepatocellular carcinoma

Manal Hassan, Ahmed Kaseb, Donghui Li, Dalia Moghazy, Jean-Nicolas Vauthey, Steven Curley, Eddie Abdalla, James Abbruzzese

Cancer Res (2009) 69 (9_Supplement): 2139.

Published: 01 May 2009

View article

Journal Articles

Abstract #2759: Thymoquinone-induced E2F-1 downregulation and induction of apoptosis enhances gemcitabine effects in pancreatic cancer

Ahmed Kaseb, KB Harikumar, AB Kunnumakkara, A Deorukhkar, James Abbruzzese, Sunil Krishnan, Bharat Aggarwal, Sushovan Guha

Cancer Res (2009) 69 (9_Supplement): 2759.

Published: 01 May 2009

View article

Journal Articles

Abstract #1613: Overexpression of Axl in pancreatic ductal carcinoma is associated with tumor invasion, metastasis and poor prognosis

Hua Wang, Xianzhou Song, Craig Logsdon, James Abbruzzese, Douglas Evans, Huamin Wang

Cancer Res (2009) 69 (9_Supplement): 1613.

Published: 01 May 2009

View article

Journal Articles

Abstract #4363: Inhibition of mammalian target of rapamycin (mTOR) in advanced pancreatic cancer - the results of two prospective phase II studies.

Milind Javle, Shrikanth Reddy, Darren Davis, Henry Xiong, Gauri Varadhachary, David Fogelman, Ahmed Kaseb, Robert Wolff, James Abbruzzese

Cancer Res (2009) 69 (9_Supplement): 4363.

Published: 01 May 2009

View article

Journal Articles

Abstract #LB-148: Mast cells in the tumor microenvironment are essential for the tumorigenesis of pancreatic ductal adenocarcinoma (PDAC)

Ying Ma, Baoan Ji, Huamin Wang, Yan Liu, Defeng Deng, Jennifer McQuade, Willem Overwijk, Gregory Lizée, James Abbruzzese, Yong-Jun Liu, Patrick Hwu, Craig Logsdon, Stephen Ullrich, David Chang

Cancer Res (2009) 69 (9_Supplement): LB-148.

Published: 01 May 2009

View article

Journal Articles

Abstract #2783: TGF-\#946;- activated kinase 1 (TAK1) is a drugable target for pancreatic cancer (PC) chemosensitization

Davide Melisi, Qianghua Xia, James Abbruzzese, Paul Chiao

Cancer Res (2009) 69 (9_Supplement): 2783.

Published: 01 May 2009

View article

Journal Articles

Abstract #1168: Characterization of evolving inflammatory status in microenvionment in a transgenic spontaneous PDAC model and correlation with clinical outcomes in human PDAC patients

Ying Ma, Baoan Ji, Huamin Wang, Yan Liu, Defeng Deng, James Abbruzzese, Stephen Ullrich, Yong-Jun Liu, Patrick Hwu, Craig Logsdon, David Chang

Cancer Res (2009) 69 (9_Supplement): 1168.

Published: 01 May 2009

View article

Journal Articles

Abstract #2425: Gene expression profiling implicates EMT in global drug resistance in pancreatic cancer

Woonyoung choi, Thiru Arumugam, Keith Fournier, Vijaya Ramachandran, James Abbruzzese, Gary Gallick, Craig Logsdon, David McConkey

Cancer Res (2009) 69 (9_Supplement): 2425.

Published: 01 May 2009

View article

Journal Articles

Abstract #2111: Effect of IGF gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer

Suzuki Hideo, Yanan Li, Xiaoqun Dong, Manal Hassan, Ichinosuke Hyodo, James Abbruzzese, Donghui Li

Cancer Res (2009) 69 (9_Supplement): 2111.

Published: 01 May 2009

View article

Journal Articles

Abstract #84: Association of Body Mass Index with Risk, Age of Onset and Survival of Pancreatic Cancer

Donghui Li, jeffrey morris, Jun Liu, Manal Hassan, Rena Day, Melissa Bondy, Douglas Evans, James Abbruzzese

Cancer Res (2009) 69 (9_Supplement): 84.

Published: 01 May 2009

View article

Journal Articles

Abstract #3165: Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of notch signaling pathway

Zhiwei Wang, Yiwei Li, Dejuan Kong, Sanjeev Banerjee, Aamir Ahmad, Asfar Azmi, Shadan Ali, James Abbruzzese, Gary Gallick, Fazlul Sarkar

Cancer Res (2009) 69 (9_Supplement): 3165.

Published: 01 May 2009

View article

Journal Articles

Interaction of the SULT1A1 and NAT gene polymorphisms with dietary mutagen intake in modification of the risk of pancreatic cancer

Hideo Suzuki, Yanan Li, Manal Hassan, Melissa Bondy, James Abbruzzese, Donghui Li, Li Jiao, Mark Doll, David Hein, Rena Day

Cancer Res (2008) 68 (9_Supplement): 4737.

Published: 01 May 2008

View article

Journal Articles

Old NSAID but new anticancer agent: Tolfenamic acid inhibits pancreatic cancer growth and sensetizes tumor to radiotherapy through downregulation of Sp proteins

Santhi Konduri, Jimmie Colon, Stephen Safe, James Abbruzzese, Cheryl Baker, Maen Abdelrahim

Cancer Res (2008) 68 (9_Supplement): 2312.

Published: 01 May 2008

View article

Journal Articles

Insulin-like growth factor gene polymorphisms and risk of pancreatic cancer

Donghui Li, Hideo Suzuki, Xiaoqun Dong, Taro Okazaki, Manal Hassan, James Abbruzzese

Cancer Res (2008) 68 (9_Supplement): 4681.

Published: 01 May 2008

View article

Journal Articles

Gemcitabine resistance in cultured pancreatic tumor cells is associated with down regulation of PTEN and a mesenchymal phenotype

michael kim, Ami Shah, Jing Zhang, Nila Parikh, James Abbruzzese, Gary Gallick

Cancer Res (2008) 68 (9_Supplement): 2460.

Published: 01 May 2008

View article

Journal Articles

Proteasome mediated degradation and the functions of hematopoietic progenitor kinase-1 (HPK1) in pancreatic cancer

Hua Wang, Xianzhou Song, Yue Hu, Craig Logsdon, Tse-Hua Tan, James Abbruzzese, Douglas Evans, Stanley Hamilton, Huamin Wang

Cancer Res (2008) 68 (9_Supplement): 893.

Published: 01 May 2008

View article

Journal Articles

Phase IB study of Src inhibition with dasatinib in combination with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) and cetuximab in metastatic colorectal cancer

Scott Kopetz, Robert Wolff, Cathy Eng, Laura Henry, Katrina Glover, David Chang, Michael Overman, Gary Gallick, James Abbruzzese

Cancer Res (2008) 68 (9_Supplement): LB-69.

Published: 01 May 2008

View article

Journal Articles

A novel JAK2-STAT3 inhibitor blocks mitogenesis and angiogenesis in pancreatic cancer

Sushovan Guha, Arup Chakraborty, Ajaikumar Kunnumakkara, Slawomir Szymanski, Izabela Fokt, James Abbruzzese, Bharat Aggarwal, Timothy Madden, Waldemar Priebe

Cancer Res (2008) 68 (9_Supplement): 1305.

Published: 01 May 2008

View article

NARROW

Abstract 1449: ApoStream™, a new dielectrophoretic device for antibody-independent isolation and recovery of circulating tumor cells from blood of patients with metastatic pancreatic adenocarcinoma.

Abstract #2718: Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation

Abstract #2139: The association between diabetes mellitus and hepatocellular carcinoma

Abstract #2759: Thymoquinone-induced E2F-1 downregulation and induction of apoptosis enhances gemcitabine effects in pancreatic cancer

Abstract #1613: Overexpression of Axl in pancreatic ductal carcinoma is associated with tumor invasion, metastasis and poor prognosis

Abstract #4363: Inhibition of mammalian target of rapamycin (mTOR) in advanced pancreatic cancer - the results of two prospective phase II studies.

Abstract #LB-148: Mast cells in the tumor microenvironment are essential for the tumorigenesis of pancreatic ductal adenocarcinoma (PDAC)

Abstract #2783: TGF-\#946;- activated kinase 1 (TAK1) is a drugable target for pancreatic cancer (PC) chemosensitization

Abstract #1168: Characterization of evolving inflammatory status in microenvionment in a transgenic spontaneous PDAC model and correlation with clinical outcomes in human PDAC patients

Abstract #2425: Gene expression profiling implicates EMT in global drug resistance in pancreatic cancer

Abstract #2111: Effect of IGF gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer

Abstract #84: Association of Body Mass Index with Risk, Age of Onset and Survival of Pancreatic Cancer

Abstract #3165: Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of notch signaling pathway

Interaction of the SULT1A1 and NAT gene polymorphisms with dietary mutagen intake in modification of the risk of pancreatic cancer

Old NSAID but new anticancer agent: Tolfenamic acid inhibits pancreatic cancer growth and sensetizes tumor to radiotherapy through downregulation of Sp proteins

Insulin-like growth factor gene polymorphisms and risk of pancreatic cancer

Gemcitabine resistance in cultured pancreatic tumor cells is associated with down regulation of PTEN and a mesenchymal phenotype

Proteasome mediated degradation and the functions of hematopoietic progenitor kinase-1 (HPK1) in pancreatic cancer

Phase IB study of Src inhibition with dasatinib in combination with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) and cetuximab in metastatic colorectal cancer

A novel JAK2-STAT3 inhibitor blocks mitogenesis and angiogenesis in pancreatic cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only